Goodship, THJ;
Pinto, F;
Weston-Davies, WH;
Silva, J;
Nishimura, J-I;
Nunn, MA;
Mackie, I;
... Veys, P; + view all
(2017)
Use of the complement inhibitor Coversin to treat HSCT-associated TMA.
Blood Advances
, 1
(16)
pp. 1254-1258.
10.1182/bloodadvances.2016002832.
Preview |
Text
Mackie_1254.full.pdf - Published Version Download (1MB) | Preview |
Abstract
Finding an inherited complement abnormality in HSCT-associated TMA provides a rationale for the use of a complement inhibitor.Alternative complement inhibitors such as Coversin should be considered in patients who are resistant to eculizumab.
Archive Staff Only
 |
View Item |
